Evidence map›Paper›PMID 32672466›Full record

ArticleJournal of medicinal chemistry2020

Correction to "A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction".

Saktimayee M Roy, George Minasov, Ottavio Arancio, Laura W Chico, Linda J Van Eldik, Wayne F Anderson, Jeffrey C Pelletier, D Martin Watterson

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Saktimayee M RoyORCID http://orcid.org/0000-0001-9096-0491
George Minasov
Ottavio ArancioORCID http://orcid.org/0000-0001-6335-164X
Laura W Chico
Linda J Van Eldik
Wayne F AndersonORCID http://orcid.org/0000-0003-4181-8127
Jeffrey C PelletierORCID http://orcid.org/0000-0002-0397-0681
D Martin WattersonORCID http://orcid.org/0000-0001-7605-5866

Funding

Preclinical Alzheimers Disease Drug Development of Novel MAPK InhibitorsU01AG043415 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WATTERSON, DANIEL MARTIN · 2012 to 2016
$6.2M
Development of Novel p38 MAPK Inhibitors as Therapeutics for CNS DisordersR01AG031311 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WATTERSON, DANIEL MARTIN · 2008 to 2012
$1.5M
Integrative Chemical Biology of Neurodegeneration: Foundation to Novel TherapiesR01NS056051 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WATTERSON, DANIEL MARTIN · 2008 to 2011
$1.0M
NIA NIH HHS R01 AG031311NIA NIH HHS U01 AG043415NINDS NIH HHS R01 NS056051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32672466
PMCPMC8154559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.